Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

6 results
Display

Visualization of the Vascular Course from the Right Atrium through the SVC to the Azygous Vein on 18FDG-PET/CT

Kim CH, Choe DH, Lee JC

Intravascular extension of malignancy is rare. Some cases of this have been reported, and these have mostly been seen in cases of lung cancer with extension into the pulmonary vein...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lung Cancer Along with a Mediastinal Mature Cystic Teratoma: A Case Report

Lee SY, Choi JS, Oh MH, Lee SJ, Lee CS

A mediastinal mass and 2 lung masses on the lower lobes were detected by chest CT in a 44-year old woman. The mass on the left lower lobe was diagnosed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Investigating Effective Combinations of Anti-cancer Drugs and Radiation Therapy for Treating Non-small Cell Lung Cancer with Using Two Cell Lines

Oh IJ, Cho HJ, Manaljav T, Kwon YS, Kim KS, Lim SC, Kim YC, Ahn SJ

PURPOSE: Radiotherapy had been used for treating unresectable locally advanced non-small cell lung cancer (NSCLC). However, the survival rate after radiotherapy alone is low and this primarily due to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Prognostic and Predictive Value of EGFR and HER-2 in Advanced Non-small Cell Lung Cancer Patients Who Are Treated with Cisplatin and Paclitaxel

Yoo J, Shim BY, Kang SJ

PURPOSE: Although both platinum-based drugs and third-generation drugs are commonly used as first-line therapy for patients with advanced, unresectable non-small cell lung cancer, their effectiveness and clinical outcomes vary. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer

Jeong SH, Jung JH, Lee HW, Kang SY, Choi YW, Ahn MS, Hwang YH, Oh YT, Choi JH, Sheen SS, Park KJ

PURPOSE: Concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced non-small cell lung cancer (NSCLC). Paclitaxel is an active agent against NSCLC and it has a radiosensitizing effect. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Locally Advanced Non-small Cell Lung Cancer

DeRose P, Cho J, Choy H

Locally advanced Non-small cell lung cancer (NSCLC) is a commonly encountered diagnosis. Historically the treatment of locally advanced NSCLC has involved radiation therapy. Clinical trials have shown a benefit to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr